UnknownPhase 3

Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

IranStarted 2004-03

Plain-language summary

This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Rhegmatogenous retinal detachment Exclusion Criteria: * PVR grade C * Duration of retinal detachment ≥ one month * History of cataract surgery * History of RD surgery

What they're measuring

proliferative vitreoretinopathy

retinal reattachment rate

Trial details

NCT IDNCT00370201

SponsorShahid Beheshti University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Rhegmatogenous Retinal Detachment trials